Literature DB >> 34314905

Traditional uses, phytochemistry, pharmacology, toxicology and formulation aspects of Glycosmis species: A systematic review.

Parusu Kavya Teja1, Prachi Patel1, Drashti Bhavsar1, Chintakindi Bindusri1, Kishori Jadhav1, Siddheshwar K Chauthe2.   

Abstract

The present article is a systematic and constructive review of the traditional medicinal uses, chemistry, pharmacology, toxicology, and formulation aspects of Glycosmis species. The genus Glycosmis comprise 51 accepted species broadly distributed in Australia, China, India, and South-East Asia. Traditionally, Glycosmis species are used in folk medicines to treat cancer, anaemia, rheumatism, fever, cough, liver-related problems, skin ailments, intestinal worm infections, wounds, and facial inflammation. This review aims to provide readers with the latest information highlighting chemical constituents isolated from the Glycosmis species, plant parts utilized for their isolation and their pharmacological activities. So far, 307 chemical constituents have been isolated and characterized from different species of the genus Glycosmis; among these constituents, alkaloids, flavonoids, terpenoids, phenolics, and sulphur-containing amides are the major bioactive compounds. Modern pharmacological studies have shown that the crude extracts and compounds isolated from this genus exhibit a broad spectrum of biological activities like anticancer, antimicrobial, anti-inflammatory, antipyretic, antidiabetic, antioxidant, larvicidal, insecticidal, hepatoprotective, wound healing, antiviral, antidiarrheal, and anxiolytic. The carbazole and acridone alkaloids from this genus have shown potential anticancer activity in various in vitro and in vivo studies. Rare scaffolds like dimeric carbazoles, dimeric acridone alkaloids, flavanocoumarins and sulphur-containing amides from this genus need further exploration for their potential bioactivity. This article also briefs about the toxicological screening and discusses various polyherbal and nano formulation aspects of Glycosmis species. Most of the pharmacological studies reported from this genus were carried out in vitro. An in-depth in vivo and toxicology evaluation of the crude extracts and isolated specialized compounds is required to explore the full therapeutic potential of this genus.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glycosmis species; Medicinal uses; Pharmacology; Phytochemistry; Rutaceae; Toxicology

Year:  2021        PMID: 34314905     DOI: 10.1016/j.phytochem.2021.112865

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  2 in total

1.  Cytotoxic constituents of Glycosmis ovoidea collected in Vietnam.

Authors:  Peter J Blanco Carcache; Gerardo D Anaya Eugenio; Tran Ngoc Ninh; Curtis E Moore; José Rivera-Chávez; Yulin Ren; Djaja D Soejarto; A Douglas Kinghorn
Journal:  Fitoterapia       Date:  2022-08-10       Impact factor: 3.204

2.  Chloroplast genome structure and phylogenetic analysis of Glycosmis parviflora (Sims) Little 1948, a folk medicinal plant featured in Lingnan Region, China.

Authors:  Aimin Chen; Fang Li; Xuena Xie; Rong Huang; Enwei Tian; Zhi Chao
Journal:  Mitochondrial DNA B Resour       Date:  2022-06-24       Impact factor: 0.610

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.